Nature Cancer: How Scientific Research Supports Your Business
Your researchers are empowered to push your organization ahead of the competition
Join the Chief Editor of Nature Cancer, Alexia-Ileana Zaromytidou for an inside look at this new journal and how it connects to the pharma industry. Learn about the journal’s aims & scope, publication processes, content and community engagement, and hot topic areas where Nature Cancer is publishing high quality and impactful studies that will support research, influence decision-making, and foster innovation in your corporation. With Springer Nature as your partner, you’ll gain access to efficient, reputable and competitive research that will help you to advance global health.
Alexia-Ileana Zaromytidou completed her PhD in the laboratory of Richard Treisman at the London Research Institute of Cancer Research UK (now the Francis Crick Institute) in London, UK. She carried out her postdoctoral research in the lab of Joan Massagué at Memorial Sloan Kettering Cancer Center in New York. She joined the Nature Cell Biology editorial team in 2010, championing cancer biology as a major field at the journal while also handling a broad range of other areas from core cell biology to biophysics.
Alexia was promoted to Chief Editor of Nature Cell Biology in 2015 and became the launch Chief Editor of Nature Cancer in 2019. Alexia is based in New York.